Literature DB >> 29784466

Knowledge gaps persist and hinder progress in eliminating mumps.

R Ramanathan1, E A Voigt1, R B Kennedy1, G A Poland2.   

Abstract

Mumps, a common childhood disease in the pre-vaccine era that causes swelling of the parotid salivary glands, can lead to orchitis, viral meningitis, and sensorineural deafness. While the incidence of disease decreased dramatically after the vaccine was added to standard vaccination schedules, the disease has made a substantial resurgence in recent years. As a result, it becomes critical to examine the factors involved in recurring outbreaks. Although low and incomplete vaccination coverage may be a key reason, it does not fully explain the issue due to the high rate of occurrence in populations with high vaccination coverage rates. Multiple studies suggest that waning immunity and secondary vaccine failure play a large role, the effects of which were previously masked by subclinical boosting. Significant knowledge gaps persist around the exact role and mechanism of waning immunity and demonstrate the need for more research in this area, as well as a reevaluation of mumps vaccine policy.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  Antibodies; Cytokines; Immunity, humoral; Measles-mumps-rubella vaccine; Mumps; Mumps vaccine; Mumps virus; Polymorphism, genetic; Receptors, cytokine

Mesh:

Substances:

Year:  2018        PMID: 29784466      PMCID: PMC6031229          DOI: 10.1016/j.vaccine.2018.05.067

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   4.169


  46 in total

1.  An increase in the number of mumps cases in the Czech Republic, 2005-2006.

Authors:  N Boxall; M Kubinyiova; V Príkazský; C Benes; J Cástková
Journal:  Euro Surveill       Date:  2008-04-17

2.  Outbreak of mumps in a school setting, United Kingdom, 2013.

Authors:  Erlend T Aasheim; Thomas Inns; Amy Trindall; Lynsey Emmett; Kevin E Brown; Chris J Williams; Mark Reacher
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

3.  Mumps--United States, 1985-1986.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1987-03-20       Impact factor: 17.586

4.  Mumps increase in Flanders, Belgium, 2012-2013: results from temporary mandatory notification and a cohort study among university students.

Authors:  Toon Braeye; Indra Linina; Rikka De Roy; Veronik Hutse; Magali Wauters; Pia Cox; Ruud Mak
Journal:  Vaccine       Date:  2014-06-25       Impact factor: 3.641

5.  Investigation of mumps vaccine failures in Minsk, Belarus, 2001-2003.

Authors:  Alena V Atrasheuskaya; Elena M Blatun; Michail V Kulak; Alina Atrasheuskaya; Igor A Karpov; Steven Rubin; George M Ignatyev
Journal:  Vaccine       Date:  2007-04-25       Impact factor: 3.641

6.  Measles Virus Neutralizing Antibody Response, Cell-Mediated Immunity, and Immunoglobulin G Antibody Avidity Before and After Receipt of a Third Dose of Measles, Mumps, and Rubella Vaccine in Young Adults.

Authors:  Amy Parker Fiebelkorn; Laura A Coleman; Edward A Belongia; Sandra K Freeman; Daphne York; Daoling Bi; Ashwin Kulkarni; Susette Audet; Sara Mercader; Marcia McGrew; Carole J Hickman; William J Bellini; Rupak Shivakoti; Diane E Griffin; Judith Beeler
Journal:  J Infect Dis       Date:  2015-11-23       Impact factor: 5.226

7.  Recent resurgence of mumps in the United States.

Authors:  Gustavo H Dayan; M Patricia Quinlisk; Amy A Parker; Albert E Barskey; Meghan L Harris; Jennifer M Hill Schwartz; Kae Hunt; Carol G Finley; Dennis P Leschinsky; Anne L O'Keefe; Joshua Clayton; Lon K Kightlinger; Eden G Dietle; Jeffrey Berg; Cynthia L Kenyon; Susan T Goldstein; Shannon K Stokley; Susan B Redd; Paul A Rota; Jennifer Rota; Daoling Bi; Sandra W Roush; Carolyn B Bridges; Tammy A Santibanez; Umesh Parashar; William J Bellini; Jane F Seward
Journal:  N Engl J Med       Date:  2008-04-10       Impact factor: 91.245

8.  Mumps outbreak in Orthodox Jewish communities in the United States.

Authors:  Albert E Barskey; Cynthia Schulte; Jennifer B Rosen; Elizabeth F Handschur; Elizabeth Rausch-Phung; Margaret K Doll; Kisha P Cummings; E Oscar Alleyne; Patricia High; Jacqueline Lawler; Andria Apostolou; Debra Blog; Christopher M Zimmerman; Barbara Montana; Rafael Harpaz; Carole J Hickman; Paul A Rota; Jennifer S Rota; William J Bellini; Kathleen M Gallagher
Journal:  N Engl J Med       Date:  2012-11-01       Impact factor: 91.245

9.  Bats host major mammalian paramyxoviruses.

Authors:  Jan Felix Drexler; Victor Max Corman; Marcel Alexander Müller; Gael Darren Maganga; Peter Vallo; Tabea Binger; Florian Gloza-Rausch; Veronika M Cottontail; Andrea Rasche; Stoian Yordanov; Antje Seebens; Mirjam Knörnschild; Samuel Oppong; Yaw Adu Sarkodie; Célestin Pongombo; Alexander N Lukashev; Jonas Schmidt-Chanasit; Andreas Stöcker; Aroldo José Borges Carneiro; Stephanie Erbar; Andrea Maisner; Florian Fronhoffs; Reinhard Buettner; Elisabeth K V Kalko; Thomas Kruppa; Carlos Roberto Franke; René Kallies; Emmanuel R N Yandoko; Georg Herrler; Chantal Reusken; Alexandre Hassanin; Detlev H Krüger; Sonja Matthee; Rainer G Ulrich; Eric M Leroy; Christian Drosten
Journal:  Nat Commun       Date:  2012-04-24       Impact factor: 14.919

10.  Antigenic differences between vaccine and circulating wild-type mumps viruses decreases neutralization capacity of vaccine-induced antibodies.

Authors:  M Šantak; M Lang-Balija; J Ivancic-Jelecki; T Košutić-Gulija; S Ljubin-Sternak; D Forcic
Journal:  Epidemiol Infect       Date:  2012-09-07       Impact factor: 4.434

View more
  10 in total

1.  Molecular identification and clinical characteristics of mumps virus and human herpesviruses associated with aseptic meningitis in South of Iran.

Authors:  Reza Taherkhani; Fatemeh Farshadpour
Journal:  Virusdisease       Date:  2021-07-15

2.  Immunogenicity of Mumps Virus Genotype G Vaccine Candidates in Jeryl Lynn-Immunized Mice.

Authors:  Kelsey Briggs; Cara Kirby; Ashley C Beavis; James Zengel; Preetish Patil; Christian Sauder; Biao He
Journal:  J Virol       Date:  2022-04-07       Impact factor: 6.549

3.  Novel mumps virus epitopes reveal robust cytotoxic T cell responses after natural infection but not after vaccination.

Authors:  Patricia Kaaijk; Maarten E Emmelot; Hugo D Meiring; Cécile A C M van Els; Jelle de Wit
Journal:  Sci Rep       Date:  2021-07-01       Impact factor: 4.379

4.  Assessment of Mumps Virus-Specific Antibodies: Comparison of Plaque Reduction Neutralization Test and Enzyme-Linked Immunosorbent Assay Estimates.

Authors:  Stéphanie Ravault; Damien Friel; Emmanuel Di Paolo; Adrian Caplanusi; Paul Gillard; Michael Povey; Stephane Carryn
Journal:  J Infect Dis       Date:  2019-09-26       Impact factor: 5.226

Review 5.  Mumps Outbreaks in Vaccinated Populations-Is It Time to Re-assess the Clinical Efficacy of Vaccines?

Authors:  Anna R Connell; Jeff Connell; T Ronan Leahy; Jaythoon Hassan
Journal:  Front Immunol       Date:  2020-09-18       Impact factor: 7.561

Review 6.  Current view on novel vaccine technologies to combat human infectious diseases.

Authors:  Zrinka Matić; Maja Šantak
Journal:  Appl Microbiol Biotechnol       Date:  2021-12-10       Impact factor: 4.813

7.  Introduction of Two-Dose Mumps-Containing Vaccine into Routine Immunization Schedule in Quzhou, China, Using Cox-Proportional Hazard Model.

Authors:  Zhiying Yin; Canjie Zheng; Quanjun Fang; Xiaoying Gong; Guoping Cao; Junji Li; Ziling Xiang; Wei Song
Journal:  J Immunol Res       Date:  2021-11-05       Impact factor: 4.818

8.  Notes From The Field: Mumps Outbreak in a Recently Vaccinated Population - Kosrae, Federated States of Micronesia, August-December, 2017.

Authors:  Susannah L McKay; Afeke Kambui; Livinson A Taulung; Ashley Tippins; Maribeth Eckert; Adam K Wharton; Rebecca J McNall; Carole Hickman; W Thane Hancock; Carter Apaisam; Peter Judicpa; Manisha Patel; Janell Routh
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2019-02-01       Impact factor: 17.586

9.  Antibody Levels at 3-Years Follow-Up of a Third Dose of Measles-Mumps-Rubella Vaccine in Young Adults.

Authors:  Patricia Kaaijk; Alienke J Wijmenga-Monsuur; Hinke I Ten Hulscher; Jeroen Kerkhof; Gaby Smits; Mioara Alina Nicolaie; Marianne A van Houten; Rob S van Binnendijk
Journal:  Vaccines (Basel)       Date:  2022-01-17

Review 10.  The Role of Nucleoprotein in Immunity to Human Negative-Stranded RNA Viruses-Not Just Another Brick in the Viral Nucleocapsid.

Authors:  Maja Šantak; Zrinka Matić
Journal:  Viruses       Date:  2022-03-03       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.